Model DetailsUterus adenocarcinoma
Model Name |
Uterus adenocarcinoma | Strain |
(C57BL/6 x C3H)F1 |
Tumor Inducing Agent(s) |
Chemical/Drug : Chloroethane |
Tumor Synonyms |
uterine adenocarcinoma metastasis • uterine adenocarcinoma metastasis to urinary bladder • uterine adenocarcinoma • uterine adenocarcinoma metastasis to pancreas • uterine adenocarcinoma metastasis to spleen • uterine tumor of epithelial origin • uterine adenocarcinoma metastasis to mesentary • uterine adenocarcinoma metastasis to liver • uterine adenocarcinoma metastasis to kidney • uterine adenocarcinoma metastasis to adrenal gland • uterine adenocarcinoma metastasis to lung • uterine adenocarcinoma metastasis to lymph node • uterine adenocarcinoma metastasis to heart • uterine adenocarcinoma metastasis to colon • uterine adenocarcinoma metastasis to gall bladder • uterine adenocarcinoma of endometrial origin • uterine adenocarcinoma metastasis to small intestine • uterine adenocarcinoma metastasis to stomach • uterine adenocarcinoma metastasis to ureter • uterine adenocarcinoma metastasis to ovary |
Strain Synonyms |
B6C3F1 • (C57BL/6xC3H) • F1-hybrid B6C3F1 • B6C3F1 • hybrid B6C3F1 • B6C3F1 (C3H x C57B16) • B6C3F1 hybrid |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Uterus | Female |
86% (43 of 50 mice) |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Adrenal gland | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Gallbladder | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Heart | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Intestine - Large Intestine - Colon | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Intestine - Small Intestine | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Kidney | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Liver | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Lung | Female |
48% (24 of 50 mice) |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Lymph node | Female |
36% (18 of 50 mice) |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Ovary | Female |
44% (22 of 50 mice) |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Pancreas | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Peritoneum - Mesentery | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Spleen | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Stomach | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Ureter | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| Urinary bladder | Female |
observed |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |
| (Unspecified organ) | Female |
68% (34 of 50 mice) |
108-109 weeks |
|
Picut CA, Exp Toxicol Pathol 2003 Jul;55(1):1-9 |